Text/HTML

We will be performing maintenance on this site on March 24, 2024 starting at 6:00 am until 8:00 am.  We apologize for the inconvenience.  


Mobile App

Google Play Apple Store

EasyDNNNews

Conversations and Cases: Integrating Recent Progress in the Treatment and Management of Relapsed Refractory Multiple Myeloma
Certified AMA Activity
Despite advances in the initial treatment strategies of multiple myeloma, many patients will experience an early relapse. The further management of such patients can be challenging given the various options and complex patient- and disease-related factors.

Conversations and Cases in Multiple Myeloma is a roundtable discussion activity designed to inform and guide on integrating recent progress in the management of early relapse. The expert faculty will discuss different cases with early relapse and provide guidance on safely using approved and emerging therapy to improve outcomes. The activity will be supported by downloadable slides that have key discussion and teaching points.
Review one or all activities and claim AMA credit/contact hour after completion of a brief pretest and posttest/evaluation.




Jesus Berdeja, MD Jesus Berdeja, MD
Director, Multiple Myeloma Research
Sarah Cannon Research Institute
 Paul Richardson, MD Paul Richardson, MD
Director, Clinical Research at Jerome Lipper Multiple Myeloma Center
Dana Farber Cancer Institute
 Saad Usmani, MD Saad Usmani, MD
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center

20

Supported by independent educational grants from
Bristol Myers Squibb

and Janssen Pharmaceuticals


Launch Date: March 28, 2023

Release Date: March 28, 2023

Expiration Date: February 29, 2024

February 29, 2024
Mini Module
7530
RR_MM_WebBanner(1150).png
Hematology-Oncology